Document is current
Any future updates will be listed below
-
Authors
Shuai, Yongfeng
Liu, Jiacong
Yang, Yuhong
Huang, Xuhua
Ye, Jiayue
Zhu, Linhai
Hu, Jian
-
Funding
Funding for this research was provided by:
the Key R&D Program of Zhejiang (2023C03172)
National Key Research and Development Program of China (2022YFC2407303)
Research Center for Lung Tumor Diagnosis and Treatment of Zhejiang Province (JBZX-202007)
- License Information
-
More Information
Article History
Received: 29 November 2024
Accepted: 19 June 2025
First Online: 6 July 2025
Declarations
:
: Informed consent was waived for the retrospective data by the Clinical Research Ethics Committee of The First Affiliated Hospital of Zhejiang University School of Medicine (2021 IIT No. 844). This trial was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (2021 IIT No. 844), and done in accordance with the Declaration of Helsinki (as revised in 2013) and Good Clinical Practice Guidelines.
: Not Applicable.
: The authors declare no competing interests.
